STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

SpringWorks Therapeutics to Participate in the Jefferies London Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

SpringWorks Therapeutics (Nasdaq: SWTX) has announced its participation in the upcoming Jefferies London Healthcare Conference. The company's management will engage in a fireside chat on Tuesday, November 19, 2024, at 10:30 a.m. ET in London, UK. The event will be accessible via live webcast through the Events & Presentations page on SpringWorks' investor website. A replay will be available for a time after the conference.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

STAMFORD, Conn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference, taking place in London, United Kingdom on Tuesday, November 19, 2024 at 10:30 a.m. ET.

To access the live webcast, please visit the Events & Presentations page within the Investors & Media section of the company’s website at https://ir.springworkstx.com. A replay of the webcast will be available on SpringWorks’ website for a limited time following the conference.

About SpringWorks Therapeutics

SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. OGSIVEO® (nirogacestat), approved in the United States for the treatment of adult patients with progressing desmoid tumors who require systemic treatment, is the Company’s first FDA-approved therapy. SpringWorks also has a diversified targeted therapy pipeline spanning solid tumors and hematological cancers, with programs ranging from preclinical development through advanced clinical trials. In addition to its wholly owned programs, SpringWorks has also entered into multiple collaborations with innovators in industry and academia to unlock the full potential for its portfolio and create more solutions for patients in need.

For more information, visit www.springworkstx.com and follow @SpringWorksTx on X (formerly Twitter), LinkedIn, and YouTube.

Contacts:
Investors
investors@springworkstx.com

Media
media@springworkstx.com


FAQ

When is SpringWorks Therapeutics (SWTX) presenting at the Jefferies London Healthcare Conference 2024?

SpringWorks Therapeutics will present at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 10:30 a.m. ET.

How can I watch SpringWorks Therapeutics' (SWTX) presentation at the Jefferies Conference?

You can watch the presentation via live webcast by visiting the Events & Presentations page within the Investors & Media section at https://ir.springworkstx.com.

Will there be a replay available of SpringWorks Therapeutics' (SWTX) Jefferies Conference presentation?

Yes, a replay of the webcast will be available on SpringWorks' website for a time following the conference.

What type of presentation will SpringWorks Therapeutics (SWTX) give at the Jefferies Conference?

SpringWorks Therapeutics management will participate in a fireside chat format presentation at the conference.
Springworks Therapeutics, Inc.

NASDAQ:SWTX

SWTX Rankings

SWTX Latest News

SWTX Latest SEC Filings

SWTX Stock Data

3.54B
73.28M
Biological Product (except Diagnostic) Manufacturing
Biological Products, (no Disgnostic Substances)
Link
US
STAMFORD